<DOC>
	<DOCNO>NCT00092001</DOCNO>
	<brief_summary>The purpose study test whether SU011248 activity safe patient metastatic non-small cell lung cancer ( NSCLC ) fail platinum-containing regimen docetaxel .</brief_summary>
	<brief_title>Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Sunitinib</mesh_term>
	<criteria>Histologically confirm advanced metastatic NonSmall Cell Lung Cancer cure surgery , radiation , combination thereof No 2 prior chemotherapy treatment include treatment platinum contain therapy Evidence measurable disease radiographic technique Male Female , 18 year old ECOG performance status 0 1 Resolution acute toxicity prior therapy Adequate organ function Major surgery radiation therapy within 4 week Severe hemorrhage within 4 week Previous treatment antiangiogenesis agent Diagnosis second malignancy within last five 5 year History know brain metastasis , spinal cord compression , carcinomatous meningitis Known HIV Serious acute chronic illness Current treatment another clinical trial Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Non-small cell lung cancer , carcinoma , sunitinib , Phase 2</keyword>
</DOC>